Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/SC/Rock Hill
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Rock Hill, SC

Studies commonly pay $75 to $4,500 per completed study

587 clinical trials are currently recruiting participants within 30 miles of Rock Hill. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

587studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Rock Hill right now

Top 25 of 587 recruiting studies, sorted by proximity — each links to its official registry page

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

Renal Cell Carcinoma Phase 3 Interventional 904 participants sought
Carolina Oncology Specialists, PA ( Site 9002) — Charlotte, North Carolina (22.2 mi) · Sponsor: Merck Sharp & Dohme LLC

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Phase 1 Interventional 36 participants sought
Atrium Health Levine Cancer Institute - Morehead — Charlotte, North Carolina (22.2 mi) · Sponsor: PeproMene Bio, Inc.

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

Uncontrolled Hypertension Phase 2 Interventional 280 participants sought
Retension Clinical Site — Charlotte, North Carolina (22.2 mi) · Sponsor: Retension Pharmaceuticals. Inc.

Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis

Knee Cartilage Defects Phase 3 Interventional 300 participants sought
Atrium Health Mercy — Charlotte, North Carolina (22.2 mi) · Sponsor: Medipost, Inc.

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

Aortoiliac Occlusive Disease N/A Observational 158 participants sought
Atrium Health Sanger Heart & Vascular Institute — Charlotte, North Carolina (22.2 mi) · Sponsor: W.L.Gore & Associates

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

Pulmonary Disease, Chronic Obstructive Phase 3 Interventional 981 participants sought
GSK Investigational Site — Rock Hill, South Carolina (1.2 mi) · Sponsor: GlaxoSmithKline

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

Non-Muscle Invasive Bladder Neoplasms N/A Observational 150 participants sought
Urology Specialists of the Carolinas PLLC Charlotte — Charlotte, North Carolina (22.2 mi) · Sponsor: Janssen Research & Development, LLC

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Relapsed Refractory Multiple Myeloma Phase 3 Interventional 508 participants sought
Research Site — Charlotte, North Carolina (22.2 mi) · Sponsor: AstraZeneca

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

Active Rheumatoid Arthritis Phase 2 Interventional 180 participants sought
DJL Clinical Research PLLC (Network) cIRB — Charlotte, North Carolina (22.2 mi) · Sponsor: Elevara Medicines Limited

A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.

Ankle Arthrodesis or Arthroplasty, Hindfoot Fusion N/A Interventional 126 participants sought
OrthoCarolina Research Institute, Inc — Charlotte, North Carolina (22.2 mi) · Sponsor: Kuros Biosurgery AG

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Polymyositis, Dermatomyositis Phase 3 Interventional 240 participants sought
Research Site — Charlotte, North Carolina (22.2 mi) · Sponsor: AstraZeneca

A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors

Recurrent or Metastatic Solid Tumors Phase 1 Interventional 76 participants sought
Research Site — Charlotte, North Carolina (22.2 mi) · Sponsor: Daiichi Sankyo

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

Solid Tumors, Lymphoma Phase 2 Interventional 40 participants sought
Carolinas Medical Center/ Levine Children's Hospital — Charlotte, North Carolina (22.2 mi) · Sponsor: Spectrum Pharmaceuticals, Inc

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
Carolinas Medical Center/Levine Cancer Institute — Charlotte, North Carolina (22.2 mi) · Sponsor: National Cancer Institute (NCI)

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma Phase 3 Interventional 380 participants sought
Atrium Health Levine Cancer Institute /ID# 246199 — Charlotte, North Carolina (22.2 mi) · Sponsor: AbbVie

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 93 participants sought
Carolinas Medical Center/Levine Cancer Institute — Charlotte, North Carolina (22.2 mi) · Sponsor: National Cancer Institute (NCI)

The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study

Venous Thromboses, Venous Disease N/A Interventional 165 participants sought
Atrium Health-Sanger Heart and Vascular Institute — Charlotte, North Carolina (22.2 mi) · Sponsor: W.L.Gore & Associates

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Breast Neoplasms Phase 3 Interventional 558 participants sought
Oncology Specialists of Charlotte Pa — Charlotte, North Carolina (22.2 mi) · Sponsor: BioNTech SE

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
Carolinas Medical Center/Levine Cancer Institute — Charlotte, North Carolina (22.2 mi) · Sponsor: National Cancer Institute (NCI)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Carolinas Medical Center/Levine Cancer Institute — Charlotte, North Carolina (22.2 mi) · Sponsor: National Cancer Institute (NCI)

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohns Disease Phase 3 Interventional 425 participants sought
Charlotte Gastroenterology and Hepatology, P.L.L.C — Charlotte, North Carolina (22.2 mi) · Sponsor: Hoffmann-La Roche

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Chronic Kidney Disease(CKD), Type 2 DM N/A Interventional 750 participants sought
Houston Methodist — Houston, North Carolina (22.5 mi) · Sponsor: Duke University
Google-rated

Top-rated research centers in Rock Hill

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Clinical Research Of Rock Hill

Rock Hill, SC 29732

DelRicht Research | Charlotte Clinical Trials

★ 4.8
6719 Fairview Rd Ste A, Charlotte, NC 28210
(704) 644-8469
"The team members are kind and considerate. They will answer questions and provide you with feedback you can share with your primary provider. Super P…"
— Kenya Davis, 5★

Piedmont Research Partners, LLC

★ 5.0
1040 Edgewater Corporate Pkwy Ste. 102, Indian Land, SC 29707
(803) 802-4561
"Love the girls in this office. Great experience with all of them."
— Delightful Dee, 5★

Clinical Research of Gastonia

1010 X Ray Dr # A, Gastonia, NC 28054
(704) 675-7144

OnSite Clinical Solutions

★ 4.8
11220 Elm Ln, Charlotte, NC 28277
(800) 785-3150
"I love it while I was there the employees was great"
— Gabrielle James, 5★

Rose Research Center

★ 4.9
8401 Medical Plaza Dr #275, Charlotte, NC 28262
(704) 350-2999
"I had an excellent experience I am definitely team Mary Beth and team rejoice definitely five stars for the ladies"
— Griselda Crawford, 5★

Queen City Clinical Research, PLLC

330 Billingsley Rd Ste 206?, Charlotte, NC 28211
(704) 405-3150

Carolina Blood & Cancer Care

★ 3.9 (30 reviews)
1583 Health Care Dr, Rock Hill, SC 29732
(803) 329-7772
"Zero stars for the front office. Unhelpful with no critical thinking. As they are the face of this practice, I do not recommend establishing care her…"
— Katie Hall, 1★

New Hope Clinical Research, Inc.

★ 4.2
3101 Latrobe Dr, Charlotte, NC 28211
(980) 209-9784
"They called to screen me and I’m not even depressed. Just lied because I need the money. I’m sure they haven’t called a bunch of others like they cal…"
— Pluto Enterprises LLC, 3★

Clinical trials in Rock Hill: what's recruiting

The Rock Hill area currently has 587 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Rock Hill, the most active research areas are:

  • Cancer & Oncology10 studies
  • Immune & Skin3 studies
  • Liver & Kidney2 studies
  • Heart & Vascular1 studies
  • Lungs & Breathing1 studies

Every listing shows the study phase, the recruiting site and its distance from Rock Hill, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Rock Hill

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Rock Hill participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Rock Hill pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Rock Hill?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Rock Hill safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
What is the difference between a research center and a hospital study in Rock Hill?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Rock Hill typically complete one or two studies per year.

Paid clinical trials near Rock Hill

Other metros within reach

More of SC

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts